|
Thomson Scientific Congress Reports
Meeting Summaries for the 16th
International IRA Conference
As the
official media partner to the Inflammation Research
Association at the 15th International Conference on
Inflammation, Thomson Reuters will be providing delegates
with a collection of reviews featuring the latest
intelligence on investigational drugs and research
released at the Conference. The reviews will be written by
an "on-site Conference reporter" from Thomson Reuter's
Scientific division and will be accessible daily during
the Conference through the official Conference WEB site.
Features of this Service
Available one
week in advance of the Conference:
Early birds can peruse the event preview to identify those
sessions that are a 'must-see' for those working in the
field of inflammation research.
Daily updates:
Delegates can keep abreast of the
hottest news as it unfolds by accessing daily reviews of
the latest disclosures on drug discovery and research with
three overnight reports available on the WEB site as the
meeting progresses.
How to Access the Meeting
Summaries
To access
the meeting summaries, click
here and enter your username password sent to all
delegates by e-mail prior to the meeting.
If you do
not have or have lost your password or you are
experiencing difficulties in logging in, please contact
Richard Griffiths (richard.j.griffiths@pfizer.com)
for further assistance. While at the meeting, please
contact the IRA registration desk in the case of any
difficulties.
Thomson
Pharma/IDdb3 subscribers can also view the histories of
many of the drugs detailed, major competitor products,
chemical structures and patents, by accessing directly
Thomson Pharma (www.thomsonpharma.com)
or the IDdb (www.iddb3.com)
in the usual way.
About Thomson Pharma
Thomson
Pharma was developed to help pharmaceutical companies
make better decisions faster. It integrates information
from Thomson Scientific with information from other
Thomson sources, including the Financial, Healthcare and
Legal and Regulatory groups. Thomson Pharma’s core content
areas include drug information, intellectual property
data, literature and news, company data, chemical
information, sequence data and drug target information,
enhanced with value added content resources and powerful
search tools.
www.thomsonpharma.com
^ TOP of PAGE
|
